文献速递生殖医学

预测英国受监管卵子库494个玻璃化卵子捐赠周期临床结局的因素

Factors predicting clinical outcomes from 494 vitrified oocyte donation cycles at a UK-regulated egg bank.
PubMed 文献 · Reprod Biomed Online · 2021-05-24

该回顾性队列研究纳入494名18-35岁卵子捐赠者及559名受体,分析供体年龄、AMH等对获卵数及受体妊娠结局的预测作用。供体年龄和AMH是获卵数的独立预测因素,受体BMI和既往流产史降低累积活产率,选择23-29岁供体可能提高活产率。

要点

  • 供体年龄和AMH是获卵总数及成熟卵数的独立预测因素。
  • 受体BMI升高和既往流产史降低累积活产率。
  • 选择23-29岁供体而非更年轻供体可能提高受体活产率。

核心结论

  • 供体年龄和AMH是卵子产量的独立预测因素,升高受体BMI和流产史降低累积活产率,选择23-29岁供体可能提高活产率。

研究设计与样本

  • 回顾性队列研究,纳入494名18-35岁 altruistic 卵子捐赠者,其中340名与559名受体匹配。

主要发现

  • 供体年龄和AMH预测获卵总数(P=0.030和P<0.001)及成熟卵数(P=0.011和P<0.001)。
  • 30-35岁且AMH 15-29.9 pmol/l的供体获卵总数(P=0.004)和成熟卵数(P<0.001)低于18-24岁供体。
  • AMH阈值至39.9 pmol/l时,AMH升高预测更高的获卵总数(<15 vs 15-29.9 pmol/l,P=0.001;15-29.9 vs 30-39.9 pmol/l,P<0.001;30-39.9 vs ≥40 pmol/l,P=1.0)和成熟卵数(<15 vs 15-29.9 pmol/l,P=0.005;15-29.9 vs 30-39.9 pmol/l,P=0.006;30-39.9 vs ≥40 pmol/l,P=1.0)。
  • 受体中,每接受卵子的可移植胚胎率、受精率及达到主要结局所需胚胎移植次数预测累积临床妊娠(P=0.011、P=0.017和P<0.001)和活产(P=0.008、P=0.012和P<0.001)率。
  • 受体BMI(P=0.024)和既往流产史(P=0.045)预测累积活产率;供体年龄18-22岁较23-29岁首次胚胎移植后受体临床妊娠(P=0.004)和活产(P=0.001)发生率更低。

临床怎么用

  • 可利用供体年龄和AMH预测卵子产量,优化供体选择。
  • 关注受体BMI和流产史以评估累积活产率。
  • 优先选择23-29岁供体而非更年轻供体,可能改善受体结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Do donor age, AMH, AFC, BMI and reproductive history predict response to ovarian stimulation? Do donor and recipient clinical markers and embryology parameters predict recipient pregnancy and live birth? DESIGN: Retrospective cohort study of 494 altruistic oocyte donors aged 18-35 years; 340 were matched to 559 recipients. Predictors of donor total oocyte yield and total mature oocyte yield were identified. Total and mature oocyte number were compared according to stratified donor AMH and age. Donor, recipient and embryology parameters predictive of recipient primary outcomes (clinical pregnancy and live birth) were identified. RESULTS: Donor age and AMH predicted total oocyte yield (P = 0.030 and P < 0.001)) and total mature oocyte yield (P = 0.011 and P < 0.001). Donors aged 30-35 years with AMH 15-29.9 pmol/l had lower total oocyte yield (P = 0.004) and mature oocyte yield (P < 0.001) than donors aged 18-24 years. Up to an AMH threshold of 39.9 pmol/l, increasing AMH levels predicted higher total oocyte yield (<15 pmol/l versus 15-29.9 pmol/l, P = 0.001; 15-29.9 pmol/l versus 30-39.9 pmol/l, P < 0.001; 30-39.9pmol/l versus ≥ 40 pmol/l, P = 1.0) and mature oocyte yield (<15 pmol/l versus 15-29.9 pmol/l, P = 0.005; 15-29.9 pmol/l versus 30-39.9 pmol/l, P = 0.006; 30-39.9 pmol/l versus ≥40 pmol/l, P = 1.0). In recipients, the rate of transferrable embryos per oocytes received, fertilized and number of embryo transfers needed to achieve the primary outcome were predictors of cumulative clinical pregnancy (P = 0.011, P = 0.017 and P < 0.001) and live birth (P = 0.008, P = 0.012 and P < 0.001) rates. Recipient BMI (P = 0.024) and previous miscarriages (P = 0.045) were predictors of cumulative live birth rate. Donor age 18-22 years was associated with a lower incidence of recipient clinical pregnancy (P = 0.004) and live birth (P = 0.001) after the first embryo transfer versus donor age 23-29 years. CONCLUSIONS: Donor age and AMH are independent predictors of oocyte yield. Raised recipient BMI and history of miscarriages reduce cumulative live birth rates, which may be increased by selecting donors aged 23-29 years, instead of younger donors.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Pataia V, Nair S, Wolska M, et al. Factors predicting clinical outcomes from 494 vitrified oocyte donation cycles at a UK-regulated egg bank. Reprod Biomed Online. 2021. PMID: 34326005. doi:10.1016/j.rbmo.2021.05.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。